Skip to main content

Table 3 The Pittsburgh Sleep Quality Index

From: Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study

 

PEA

Placebo

Baseline

11.2 ± 2.8

11.7 ± 3.3

Day 5

9.0 ± 2.7

9.8 ± 3.4

Week 2

8.2 ± 2.7

8.8 ± 3.3

Week 4

7.8 ± 3.0

8.2 ± 3.4

Week 8

7.6 ± 3.1

7.7 ± 3.6

  1. N.B. Data presented as mean ± standard deviation; PEA palmitoylethanolamide
Back to article page

Sleep Science and Practice

ISSN: 2398-2683

Contact us